BA
The Boeing Company
BA has the edge over BKYI overall, supported by stronger fundamentals and lower modeled downside.
BKYI
BIO-key International, Inc.
BKYI offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
BKYI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
BKYI's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
BKYI PE Valuation
BKYI has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
BKYI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BKYI's losses to shrink, with revenue growing.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over BKYI on earnings quality, reporting a profit while its opponent remains loss making.
BKYI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$7.93 | +$3.37 |
| Q1 2026 | -$9.37 | +$9.93 |
| Q4 2025 | -$10.77 | +$10.13 |
| Q3 2025 | -$8.90 | +$53.20 |
| Q2 2025 | -$11.30 | +$59.50 |
| Q1 2025 | -$19.30 | +$70.30 |
| Q4 2024 | -$20.90 | +$70.90 |
| Q3 2024 | -$62.10 | +$135.55 |
BKYI lost $7.93 per share over the past year, a smaller loss than the year before.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over BKYI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over BKYI on profitability, with a higher operating margin.
BKYI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.9M | +13% |
| Q1 2026 | $2.1M | +33% |
| Q4 2025 | $1.1M | -26% |
| Q3 2025 | $1.5M | -28% |
| Q2 2025 | $1.7M | +49% |
| Q1 2025 | $1.6M | -26% |
| Q4 2024 | $1.5M | -20% |
| Q3 2024 | $2.1M | +18% |
BKYI's revenue is recovering but still below its 2023 peak: $2M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -28% | +36 points |
| Q1 2026 | -7.3% | +33 points |
| Q4 2025 | -389% | -302 points |
| Q3 2025 | -58% | -31 points |
| Q2 2025 | -64% | +81 points |
| Q1 2025 | -40% | -17 points |
| Q4 2024 | -87% | +63 points |
| Q3 2024 | -27% | +15 points |
BKYI's operating margin was −28% last quarter, up 36 points from the same quarter a year ago.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over BKYI on cash generation, producing positive trailing cash flow while its opponent burns cash.
BKYI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$845.7K | +$35.7K |
| Q1 2026 | -$358K | +$481.9K |
| Q4 2025 | -$1.8M | -$1.3M |
| Q3 2025 | -$1.1M | +$173.1K |
| Q1 2025 | -$839.9K | -383% |
| Q4 2024 | -$504.6K | +$1M |
| Q3 2024 | -$1.3M | -$1.1M |
| Q1 2024 | $297.1K | +$2.2M |
BKYI has burned cash in almost every quarter: −$4M over the past year, against −$4M the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
BKYI Net Leverage
BKYI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
BKYI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.9 | Neutral |
| Stochastic | 29.9 | Neutral |
BKYI's weekly RSI is 42 (neutral) and its Stochastic is 30 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
BKYI PE vs Industrials Sector
BKYI has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
BKYI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.41 | 7.1% above |
| 20 week MA | $3.16 | 18% below |
| 50 week MA | $4.70 | 45% below |
| 100 week MA | $7.00 | 63% below |
| 200 week MA | $33.8 | 92% below |
BKYI has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over BKYI on returns for 2026, with the stronger performance.
BKYI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $705.9 | $624.6 | -12% |
| 2021 | $624.6 | $417.6 | -33% |
| 2022 | $417.6 | $108.1 | -74% |
| 2023 | $108.1 | $30.0 | -72% |
| 2024 | $30.0 | $14.1 | -53% |
| 2025 | $14.1 | $6.06 | -57% |
| 2026 YTD | $6.06 | $2.58 | -57% |
BKYI has finished every year since 2020 lower, and it's down 57% so far in 2026.